Lunai Bioworks Inc.
LNAI
$0.56
$0.34162.77%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -26.73% | -39.75% | |||
| Depreciation & Amortization | -72.77% | 27.30% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -26.37% | -39.80% | |||
| Operating Income | 26.37% | 39.80% | |||
| Income Before Tax | -163.83% | 102.22% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -163.83% | 102.22% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -163.83% | 102.22% | |||
| EBIT | 26.37% | 39.80% | |||
| EBITDA | 25.57% | 40.34% | |||
| EPS Basic | -161.18% | 101.74% | |||
| Normalized Basic EPS | 27.53% | 53.28% | |||
| EPS Diluted | -161.18% | 101.74% | |||
| Normalized Diluted EPS | 27.53% | 53.28% | |||
| Average Basic Shares Outstanding | 4.27% | 27.87% | |||
| Average Diluted Shares Outstanding | 4.27% | 27.87% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||